[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Fakih IVF Fertility Center\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":74},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":27,"conditions":28,"keywords":30,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100645036","phase-2-thymosin-1-for-recurrent-implantation-failure-100645036",false,"NCT07675980","Thymosin-α1 for Recurrent Implantation Failure","Thymosin-α1 for Recurrent Implantation Failure Following Transfer of PGT-a Tested Embryo: A Randomized, Double-Blind, Placebo-Controlled Trial","Thy-α1 for RIF","Inclusion Criteria:\n\n1. -Women 18-40 years\n2. -RIF- ≥2 failed embryo transfers with PGT-a tested euploid embryos\n3. \\- Normal parental karyotypes\n4. \\- Normal uterine cavity on imaging\n5. \\- Negative antiphospholipid panel\n6. \\- Thyroid and prolactin controlled within local reference standards\n\nExclusion Criteria:\n\n1. Identified\u002Fcorrectable non-immune cause of RPL (chromosomal, anatomic, endocrine)\n2. \\- Active malignancy\n3. -Active infection\n4. \\- Uncontrolled systemic disease\n5. \\- Current systemic immunosuppression","FEMALE","18 Years","40 Years",{"count":21,"type":22},136,"ESTIMATED","INTERVENTIONAL",[25,26],"PHASE2","PHASE3","Clinical trial evaluating the safety and efficacy of Thymosin-α1 (Tα1) as an adjunctive immunomodulatory therapy in women with unexplained recurrent implantation failure (RIF) undergoing IVF\u002FICSI cycles.",[29],"Recurrent Implantation Faliure",[31,32,33,34],"Thymosin","recurrent implantation failure","Thymosin alpha","PGT-a tested embryos","RECRUITING","2026-06-29",{"date":38,"type":39},"2026-06-30","ACTUAL",{"date":41,"type":39},"2026-02-11",{"date":43,"type":22},"2027-06",{"name":45,"class":46},"Fakih IVF Fertility Center","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":47},"100645392","an-investigation-of-the-effect-of-vitamin-d-level-during-frozen-embryo-transfer-fet-in-ivf-and-pregnancy-outcomes-100645392","NCT07681115","An Investigation of the Effect of Vitamin D Level During Frozen Embryo Transfer (FET) in IVF and Pregnancy Outcomes","Vitamin D Levels and Pregnancy Outcomes Following Frozen Embryo Transfer (FET) in the UAE","VitD in FET","Inclusion:\n\n* Women undergoing frozen embryo transfer (FET) at Fakih IVF.\n* Age between 18 and 40 years.\n* Body mass index (BMI) between 18 and 40 kg\u002Fm².\n* Patients who had serum vitamin D levels assessed within three months prior to FET\n* Supplementation with Vitamin D if deficient \\\u003C 30 ng\u002FmL (75 nmol\u002FL).\n\nExclusion:\n\n* Age below 18 years or above 40 years.\n* BMI below 18 kg\u002Fm² or above 40 kg\u002Fm².\n* Patients who did not have vitamin D levels measured within three months prior to FET.\n* Patients who were found to have low vitamin D levels but did not receive supplementation.\n* Patients with recurrent implantation failure (RIF).\n* Patients with known uterine factors affecting implantation (e.g., congenital uterine anomalies, intrauterine adhesions, submucosal fibroids).\n* Patients with significant medical comorbidities that may affect pregnancy outcomes.",{"count":57,"type":22},126,"OBSERVATIONAL","Vitamin D is best known for keeping our bones healthy, but growing research suggests it may also play a role in fertility. Many IVF clinics now routinely check vitamin D levels and prescribe supplements before treatment, but the science is still unclear on whether this actually improves the chances of pregnancy.\n\nOur study, based in the UAE, aims to find out whether a woman's vitamin D level on the day of her frozen embryo transfer (FET) makes a difference to whether she becomes pregnant and delivers a baby. The UAE is an ideal setting for this research, as vitamin D deficiency is particularly common in the region. The findings could shape how fertility clinics screen and treat women seeking fertility treatment in the future.",[61,62],"Vitamin D Insufficiency","In Vitro Fertilization and Embryo Transfer",[64,65],"frozen embryo transfer cycle","Vitamin D","2026-06-26",{"date":68,"type":39},"2026-07-02",{"date":70,"type":39},"2026-06-01",{"date":72,"type":22},"2027-08",{"name":45,"class":46},""]